A Win For BioCryst Pharmaceuticals, Inc.

Mon, Feb 01, 2021 at 05:33 PM
A Win For BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc. (BCRX:NASDAQ) shot up at $11.85, a gain of 39.1%. On Fri 29 Jan 21, BCRX:NASDAQ touched a New 2-Week Low of $8.52. The stock appeared on our News Catalysts scanner on Mon 01 Feb 21 at 01:59 PM in the 'BIOTECH' category. From Fri 15 Jan 21, the stock recorded 33.33% Up Days and 40.00% Green Days

The share price of the company has been moving sideways in recent weeks.

About BioCryst Pharmaceuticals, Inc. (BCRX:NASDAQ)

Biocryst Pharmaceuticals Inc is a pharmaceutical company that designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in the infectious and inflammatory diseases. It has its focus on oral treatments for rare diseases.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.